Alina Iuga Selected Research

Spontaneous Remission

11/2020

Spontaneous Regression and Complete Response to Immune Checkpoint Blockade in a Case of High-Grade Neuroendocrine Carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alina Iuga Research Topics

Disease

8	Neoplasms (Cancer) 12/2023 - 02/2015
5	Adenocarcinoma 12/2023 - 04/2018
4	Inflammation (Inflammations) 01/2023 - 11/2017
3	Colitis 01/2021 - 01/2014
2	Deglutition Disorders (Dysphagia) 10/2023 - 01/2022
2	Eosinophilic Esophagitis 01/2023 - 01/2022
2	Disease Progression 01/2018 - 11/2017
2	Weight Loss (Weight Reduction) 11/2017 - 01/2014
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2023
1	Hypoxia (Hypoxemia) 03/2023
1	Eosinophilia 01/2023
1	Fistula 01/2023
1	Crohn Disease (Crohn's Disease) 01/2023
1	Carcinoma (Carcinomatosis) 01/2021
1	Hepatitis 01/2021
1	Pancreatitis 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Neuroendocrine Carcinoma 11/2020
1	Spontaneous Remission 11/2020
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2020
1	Cysts 01/2020
1	Celiac Disease (Celiac Sprue) 08/2019
1	Liver Failure 01/2018
1	Liver Diseases (Liver Disease) 01/2018
1	Wolman Disease (Wolman's Disease) 01/2018
1	Ileitis 11/2017
1	Necrotizing Enterocolitis 11/2017
1	End Stage Liver Disease 02/2015
1	Liver Neoplasms (Liver Cancer) 02/2015
1	Dengue (Dengue Fever) 05/2010

Drug/Important Bio-Agent (IBA)

3	EnzymesIBA 03/2023 - 05/2010
3	Immune Checkpoint InhibitorsIBA 01/2021 - 11/2020
2	Gemcitabine FDA Link 12/2023 - 01/2023
2	Proteins (Proteins, Gene)FDA Link 03/2023 - 01/2023
2	Proton Pump InhibitorsIBA 01/2023 - 01/2022
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2021 - 04/2018
2	LipidsIBA 01/2020 - 01/2018
2	CytokinesIBA 11/2017 - 01/2014
1	plerixafor FDA Link 12/2023
1	mepolizumabIBA 10/2023
1	Transcription Factors (Transcription Factor)IBA 03/2023
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 03/2023
1	Oxygen (Dioxygen)IBA 03/2023
1	Basic Helix-Loop-Helix Transcription FactorsIBA 03/2023
1	Hematoxylin (Haematoxylon)IBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2023
1	Sulfonic AcidsIBA 01/2023
1	AntibodiesIBA 01/2021
1	Prednisolone (Predate)FDA LinkGeneric 01/2021
1	Mitogen-Activated Protein KinasesIBA 11/2020
1	ruxolitinibIBA 10/2020
1	Cysteine (L-Cysteine)FDA Link 01/2020
1	Cystine (L-Cystine)IBA 01/2020
1	Amino Acids FDA Link 01/2020
1	Glutens (Glutelin)IBA 08/2019
1	Monoclonal AntibodiesIBA 04/2018
1	atosibanIBA 11/2017
1	Dextrans (Dextran)FDA Link 11/2017
1	Oxytocin (Pitocin)FDA LinkGeneric 11/2017
1	4-(4-sulfophenylazo)-2-mercuriphenol (SAMP)IBA 11/2017
1	Serotonin (5 Hydroxytryptamine)IBA 11/2017
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 11/2017
1	AntigensIBA 11/2017
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 02/2015
1	Glycoproteins (Glycoprotein)IBA 02/2015
1	Food Allergy Herbal Formula-2IBA 01/2014
1	Interleukin-17 (Interleukin 17)IBA 01/2014
1	Interleukin-6 (Interleukin 6)IBA 01/2014
1	ImmunosorbentsIBA 05/2010
1	Immunoglobulin M (IgM)IBA 05/2010
1	Immunoglobulin G (IgG)IBA 05/2010

Therapy/Procedure

4	Therapeutics 12/2023 - 04/2018
1	Drug Therapy (Chemotherapy) 12/2023
1	Anesthesia 01/2023
1	Aftercare (After-Treatment) 01/2022
1	Enzyme Replacement Therapy 01/2018
1	Liver Transplantation 01/2018
1	Splenectomy 01/2018